64.83
0.40 (0.62%)
Penutupan Terdahulu | 64.43 |
Buka | 64.25 |
Jumlah Dagangan | 2,167,577 |
Purata Dagangan (3B) | 3,609,296 |
Modal Pasaran | 14,447,041,536 |
Harga / Pendapatan (P/E TTM) | 27.24 |
Harga / Pendapatan (P/E Ke hadapan) | 14.35 |
Harga / Jualan (P/S) | 3.75 |
Harga / Buku (P/B) | 3.13 |
Julat 52 Minggu | |
Tarikh Pendapatan | 28 Jul 2025 - 1 Aug 2025 |
Margin Keuntungan | 13.83% |
Margin Operasi (TTM) | 22.17% |
EPS Cair (TTM) | 2.38 |
Pertumbuhan Hasil Suku Tahunan (YOY) | -1.20% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | -18.50% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 54.80% |
Nisbah Semasa (MRQ) | 3.24 |
Aliran Tunai Operasi (OCF TTM) | 1.13 B |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 775.88 M |
Pulangan Atas Aset (ROA TTM) | 6.92% |
Pulangan Atas Ekuiti (ROE TTM) | 11.77% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Medical Instruments & Supplies (US) | Menurun | Bercampur |
Medical Instruments & Supplies (Global) | Menurun | Menurun | |
Stok | Hologic, Inc. | Menurun | Menurun |
AISkor Stockmoo
Konsensus Penganalisis | -0.5 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 1.0 |
Purata Bergerak Teknikal | -1.0 |
Osilator Teknikal | 2.0 |
Purata | 0.38 |
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. |
|
Sektor | Healthcare |
Industri | Medical Instruments & Supplies |
Gaya Pelaburan | Mid Core |
% Dimiliki oleh Orang Dalam | 0.86% |
% Dimiliki oleh Institusi | 102.63% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Mitsubishi Ufj Asset Management Co., Ltd. | 31 Mar 2025 | 4,473,098 |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 71.00 (Raymond James, 9.52%) | Beli |
Median | 70.00 (7.98%) | |
Rendah | 62.00 (Evercore ISI Group, -4.37%) | Pegang |
Purata | 67.60 (4.27%) | |
Jumlah | 2 Beli, 3 Pegang | |
Harga Purata @ Panggilan | 54.47 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Stephens & Co. | 13 May 2025 | 70.00 (7.97%) | Beli | 57.12 |
Morgan Stanley | 05 May 2025 | 65.00 (0.26%) | Pegang | 52.73 |
Evercore ISI Group | 02 May 2025 | 62.00 (-4.37%) | Pegang | 54.16 |
RBC Capital | 02 May 2025 | 70.00 (7.97%) | Pegang | 54.16 |
Raymond James | 02 May 2025 | 71.00 (9.52%) | Beli | 54.16 |
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
22 May 2025 | Pengumuman | Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients |
13 May 2025 | Pengumuman | Hologic to Webcast Presentations at Upcoming Investor Conferences |
01 May 2025 | Pengumuman | Hologic Announces Financial Results for Second Quarter of Fiscal 2025 |
24 Apr 2025 | Pengumuman | Groundbreaking New Data on Hologic’s AI-Powered Mammography Technology to Be Presented at SBI |
22 Apr 2025 | Pengumuman | Hologic Details Environmental, Social and Governance Efforts — Including Expanded Environmental Ambitions — in New Sustainability Report |
04 Apr 2025 | Pengumuman | Wayde McMillan Elected to Hologic Board of Directors |
03 Apr 2025 | Pengumuman | Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |